Analyst Ratings for Arcturus Therapeutics (ARCT) [Neutrals]
ARCT Rating Summary
ARCT Price Target Summary
- Highest: $87.00 (Canaccord Genuity)
- Lowest: $40.00 (Citi)
- Average: $64.80
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$64.80 (+146.2%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 64%
Avg. $ Target:
$64.80 (+146.2%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 64%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/2/2022 | Barclays | Gena Wang | Upgrade | Equalweight (Underweight) |
25.00 (16.00) |
18.28 (26.32) |
43.98% | Details |
| 6/9/2020 | WBB Securities | Stephen Brozak | Downgrade | Hold (Buy) |
N/A (N/A) |
29.82 (26.32) |
-11.74% | Details |
